Pricing & Access· May 16, 2026 · 8 min readSkyrizi coverage guide: formulary, prior authorization, and patient assistanceSkyrizi (risankizumab-rzaa) is approved for psoriasis, PsA, Crohn's disease, and ulcerative colitis. Review dosing, 2026 formulary...By Ran Chen#Immunology#IL-23 Inhibitor#Prior Authorization